Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis.
about
Pharmacology and rationale for imatinib in the treatment of sclerodermaAirway symptoms and biological markers in nasal lavage fluid in subjects exposed to metalworking fluidsPooled genome-wide analysis to identify novel risk loci for pediatric allergic asthmaContributions of mass spectrometry-based proteomics to defining cellular mechanisms and diagnostic markers for systemic lupus erythematosus.Altered DNA methylation profile in idiopathic pulmonary fibrosis.Proteomic diagnosis of Sjögren's syndrome.Bronchoalveoloar lavage fluid cytokines and chemokines as markers and predictors for the outcome of interstitial lung disease in systemic sclerosis patients.Transforming growth factor beta as a therapeutic target in systemic sclerosis.Proteomics of lung cell biology and pulmonary disease.Renal fibrosis: insight from proteomics in animal models and human disease.Proteome analysis of biological fluids from autoimmune-rheumatological disorders.Systemic sclerosis biomarkers discovered using mass-spectrometry-based proteomics: a systematic review.Calprotectin in rheumatic diseases.Systematic approach to understanding the pathogenesis of systemic sclerosis.S100A9 promotes human lung fibroblast cells activation through receptor for advanced glycation end-product-mediated extracellular-regulated kinase 1/2, mitogen-activated protein-kinase and nuclear factor-κB-dependent pathways.Efficacy of low-dose imatinib mesylate for cutaneous involvement in systemic sclerosis: a preliminary report of three cases.Increased expression of S100A8 and S100A9 in patients with diffuse cutaneous systemic sclerosis. A correlation with organ involvement and immunological abnormalities.S100A9 aggravates bleomycin-induced dermal fibrosis in mice via activation of ERK1/2 MAPK and NF-κB pathways.Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.Identification of unique gene expression patterns within different lesional sites of keloids.
P2860
Q26825153-54242EEF-336E-4710-8153-EA1563A3D284Q28393528-BB5327A1-AE1E-487B-A711-418B82134CC5Q33832076-9B35BFE3-F5A3-4666-9BFB-66F572697123Q36084958-81DE2934-ABA9-4EC3-9AF3-2AA74B2611C5Q36345274-636B500C-D2AF-4DA2-9A73-A04A525B3444Q37027496-1B35EEB8-2E14-4FE4-9031-316A1F94D475Q37350899-BD3E42BC-774A-429F-9FDB-9115013A1BD2Q37428739-1C667AD3-FC96-4245-BD9D-0129ABD2998EQ37754857-04F2CA43-8598-4C18-8741-A77E2B07F1E6Q37828116-E9247783-7C2C-4A65-9906-38269AE5FC19Q37830007-17392682-2D85-40E8-B691-20544A4D40DAQ38211968-4AC80802-D36F-439E-B13F-CC2466C27AD2Q39022858-65D4974D-5A48-4A5F-A936-A48790C82B3FQ39029340-EB512417-6E39-4CAB-B190-329C93415AC3Q39150684-FE09AE43-9864-4172-B116-FD068758E86EQ43498045-D20FE8C1-D431-4AAF-9198-1FE9B5797CC6Q44751936-06D0312F-6006-4A4D-AAF8-5687D1C6899CQ49874210-F1843AE7-B21E-4180-AE3C-E0F964EC9CE6Q53470982-016246C8-CA7F-4EB1-B897-DAC9368C6265Q54546049-454BE713-769D-4D95-AC72-60F33C2997F1
P2860
Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Analysis of bronchoalveolar la ...... ogical signs of lung fibrosis.
@ast
Analysis of bronchoalveolar la ...... ogical signs of lung fibrosis.
@en
type
label
Analysis of bronchoalveolar la ...... ogical signs of lung fibrosis.
@ast
Analysis of bronchoalveolar la ...... ogical signs of lung fibrosis.
@en
prefLabel
Analysis of bronchoalveolar la ...... ogical signs of lung fibrosis.
@ast
Analysis of bronchoalveolar la ...... ogical signs of lung fibrosis.
@en
P2093
P2860
P50
P356
P1476
Analysis of bronchoalveolar la ...... logical signs of lung fibrosis
@en
P2093
P2860
P2888
P356
10.1186/AR2067
P577
2006-01-01T00:00:00Z